CAS 936345-35-6

PF-02413873

CAS : 936345-35-6

PF-02413873

Degré de pureté : ≥98%

Masse moléculaire : 359.44g/mol

Ref: 54-BUP12268

PF-02413873

CAS : 936345-35-6

PF-02413873 is a selective and potent inhibitor of the mineralocorticoid receptor. It reduces the production of low-density lipoproteins and inhibits atherosclerosis in vitro. PF-02413873 has also shown to be effective against endometriosis, which is caused by high levels of estrogen. This drug binds to the mineralocorticoid receptor on cells, preventing it from binding to messenger RNA, thus preventing protein synthesis and cell division. PF-02413873 inhibits the production of low-density lipoprotein by inhibiting cholesterol uptake in hepatocytes and by preventing cholesterol esterification in the liver.

Formule : C₁₈H₂₁N₃O₃S

Degré de pureté : Min. 95%

Masse moléculaire : 359.4 g/mol

Ref: 3D-LMB34535

PF-02413873

CAS : 936345-35-6

PF-02413873 is a competitive antagonist of nonsteroidal progesterone receptor with a Ki of 2.6 nM.

Formule : C₁₈H₂₁N₃O₃S

Degré de pureté : 99.83% - 99.89%

Couleur et forme : Solid

Masse moléculaire : 359.44

Ref: TM-T28362